These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 26816736)
1. Androgen receptor-mediated non-genomic regulation of prostate cancer cell proliferation. Liao RS; Ma S; Miao L; Li R; Yin Y; Raj GV Transl Androl Urol; 2013 Sep; 2(3):187-96. PubMed ID: 26816736 [TBL] [Abstract][Full Text] [Related]
2. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214 [TBL] [Abstract][Full Text] [Related]
3. PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells. Kaarbø M; Mikkelsen OL; Malerød L; Qu S; Lobert VH; Akgul G; Halvorsen T; Maelandsmo GM; Saatcioglu F Cell Oncol; 2010; 32(1-2):11-27. PubMed ID: 20203370 [TBL] [Abstract][Full Text] [Related]
4. Non-Genomic Actions of the Androgen Receptor in Prostate Cancer. Leung JK; Sadar MD Front Endocrinol (Lausanne); 2017; 8():2. PubMed ID: 28144231 [TBL] [Abstract][Full Text] [Related]
5. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation. Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644 [TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells. Xie Y; Wolff DW; Lin MF; Tu Y Mol Pharmacol; 2007 Jul; 72(1):73-85. PubMed ID: 17430995 [TBL] [Abstract][Full Text] [Related]
7. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance. McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453 [TBL] [Abstract][Full Text] [Related]
8. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells. Lee YF; Lin WJ; Huang J; Messing EM; Chan FL; Wilding G; Chang C Cancer Res; 2002 Nov; 62(21):6039-44. PubMed ID: 12414626 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expression. Lin DL; Whitney MC; Yao Z; Keller ET Clin Cancer Res; 2001 Jun; 7(6):1773-81. PubMed ID: 11410519 [TBL] [Abstract][Full Text] [Related]
12. Rapid signalling by androgen receptor in prostate cancer cells. Peterziel H; Mink S; Schonert A; Becker M; Klocker H; Cato AC Oncogene; 1999 Nov; 18(46):6322-9. PubMed ID: 10597231 [TBL] [Abstract][Full Text] [Related]
13. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells. Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210 [TBL] [Abstract][Full Text] [Related]
14. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells. Pandini G; Mineo R; Frasca F; Roberts CT; Marcelli M; Vigneri R; Belfiore A Cancer Res; 2005 Mar; 65(5):1849-57. PubMed ID: 15753383 [TBL] [Abstract][Full Text] [Related]
15. The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer. Chatterjee B Mol Cell Biochem; 2003 Nov; 253(1-2):89-101. PubMed ID: 14619959 [TBL] [Abstract][Full Text] [Related]
16. GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling. White MA; Tsouko E; Lin C; Rajapakshe K; Spencer JM; Wilkenfeld SR; Vakili SS; Pulliam TL; Awad D; Nikolos F; Katreddy RR; Kaipparettu BA; Sreekumar A; Zhang X; Cheung E; Coarfa C; Frigo DE Endocr Relat Cancer; 2018 Apr; 25(4):453-469. PubMed ID: 29431615 [TBL] [Abstract][Full Text] [Related]
17. Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity. Zoubeidi A; Zardan A; Beraldi E; Fazli L; Sowery R; Rennie P; Nelson C; Gleave M Cancer Res; 2007 Nov; 67(21):10455-65. PubMed ID: 17974989 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of androgen receptor transactivation function by adenovirus type 12 E1A undermines prostate cancer cell survival. Li D; Tian G; Wang J; Zhao LY; Co O; Underill ZC; Mymryk JS; Claessens F; Dehm SM; Daaka Y; Liao D Prostate; 2018 Nov; 78(15):1140-1156. PubMed ID: 30009471 [TBL] [Abstract][Full Text] [Related]
19. Regulator of G-protein signaling 2 (RGS2) inhibits androgen-independent activation of androgen receptor in prostate cancer cells. Cao X; Qin J; Xie Y; Khan O; Dowd F; Scofield M; Lin MF; Tu Y Oncogene; 2006 Jun; 25(26):3719-34. PubMed ID: 16449965 [TBL] [Abstract][Full Text] [Related]
20. Androgens activate mitogen-activated protein kinase signaling: role in neuroprotection. Nguyen TV; Yao M; Pike CJ J Neurochem; 2005 Sep; 94(6):1639-51. PubMed ID: 16011741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]